Keyword: Reckitt Benckiser Pharmaceuticals
With the feds sniffing around Indivior’s marketing of Suboxone film, the drugmaker’s former parent company is clearing its name for $1.4 billion.
In 2017, Reckitt Benckiser CEO Rakesh Kapoor touched off some big changes for the company. But he won’t stick around to see them through.
Nestlé, Unilever and Coca-Cola advanced to a second round of bidding for GSK's Indian consumer products business.
Coca-Cola is reportedly jumping into the fray for GSK's India consumer business, joining other big-name bidders such as Kraft and Danone.
More big-name suitors are jumping into the mix for GlaxoSmithKline’s Indian consumer health unit.
RB's Mucinex brand saw high spikes in brand awareness and purchase intent fueled by a high-visibility pre- and post-Super Bowl campaign.
Reckitt Benckiser is officially bowing out of the race for Pfizer’s consumer health unit, paving the way for GlaxoSmithKline to make a move.
Reports say that Nestle backed off as leader to buy Merck KGaA’s consumer businesses and that Pfizer has only two interested parties.
Pharma companies didn't air any Super Bowl advertisements for the second year in a row, although Reckitt's OTC brand Mucinex did buy into the postgame slot.
Johnson & Johnson has plenty of money coming in from overseas, thanks to U.S. tax reform. But it won’t be spending it on Pfizer’s OTC unit.
